S&P 500   3,848.16 (+0.16%)
DOW   31,949.77 (+1.44%)
QQQ   305.47 (-1.04%)
AAPL   117.83 (-2.96%)
MSFT   230.36 (-0.54%)
FB   259.00 (-2.00%)
GOOGL   2,054.17 (-2.05%)
TSLA   580.15 (-2.98%)
AMZN   3,007.24 (+0.23%)
NVDA   473.24 (-5.06%)
BABA   228.54 (-2.29%)
CGC   31.38 (+0.67%)
GE   14.21 (+4.49%)
MU   86.64 (-2.58%)
NIO   36.32 (-4.70%)
AMD   75.81 (-3.45%)
T   30.35 (+2.46%)
F   12.62 (+2.85%)
ACB   9.75 (+1.56%)
DIS   200.61 (+5.59%)
BA   227.32 (+1.84%)
NFLX   505.70 (-2.07%)
PFE   34.79 (+1.16%)
S&P 500   3,848.16 (+0.16%)
DOW   31,949.77 (+1.44%)
QQQ   305.47 (-1.04%)
AAPL   117.83 (-2.96%)
MSFT   230.36 (-0.54%)
FB   259.00 (-2.00%)
GOOGL   2,054.17 (-2.05%)
TSLA   580.15 (-2.98%)
AMZN   3,007.24 (+0.23%)
NVDA   473.24 (-5.06%)
BABA   228.54 (-2.29%)
CGC   31.38 (+0.67%)
GE   14.21 (+4.49%)
MU   86.64 (-2.58%)
NIO   36.32 (-4.70%)
AMD   75.81 (-3.45%)
T   30.35 (+2.46%)
F   12.62 (+2.85%)
ACB   9.75 (+1.56%)
DIS   200.61 (+5.59%)
BA   227.32 (+1.84%)
NFLX   505.70 (-2.07%)
PFE   34.79 (+1.16%)
S&P 500   3,848.16 (+0.16%)
DOW   31,949.77 (+1.44%)
QQQ   305.47 (-1.04%)
AAPL   117.83 (-2.96%)
MSFT   230.36 (-0.54%)
FB   259.00 (-2.00%)
GOOGL   2,054.17 (-2.05%)
TSLA   580.15 (-2.98%)
AMZN   3,007.24 (+0.23%)
NVDA   473.24 (-5.06%)
BABA   228.54 (-2.29%)
CGC   31.38 (+0.67%)
GE   14.21 (+4.49%)
MU   86.64 (-2.58%)
NIO   36.32 (-4.70%)
AMD   75.81 (-3.45%)
T   30.35 (+2.46%)
F   12.62 (+2.85%)
ACB   9.75 (+1.56%)
DIS   200.61 (+5.59%)
BA   227.32 (+1.84%)
NFLX   505.70 (-2.07%)
PFE   34.79 (+1.16%)
S&P 500   3,848.16 (+0.16%)
DOW   31,949.77 (+1.44%)
QQQ   305.47 (-1.04%)
AAPL   117.83 (-2.96%)
MSFT   230.36 (-0.54%)
FB   259.00 (-2.00%)
GOOGL   2,054.17 (-2.05%)
TSLA   580.15 (-2.98%)
AMZN   3,007.24 (+0.23%)
NVDA   473.24 (-5.06%)
BABA   228.54 (-2.29%)
CGC   31.38 (+0.67%)
GE   14.21 (+4.49%)
MU   86.64 (-2.58%)
NIO   36.32 (-4.70%)
AMD   75.81 (-3.45%)
T   30.35 (+2.46%)
F   12.62 (+2.85%)
ACB   9.75 (+1.56%)
DIS   200.61 (+5.59%)
BA   227.32 (+1.84%)
NFLX   505.70 (-2.07%)
PFE   34.79 (+1.16%)
Log in
CVE:COT

Cotinga Pharmaceuticals Inc. (COT.V) Competitors

C$0.04
-0.03 (-41.67 %)
(As of 10/14/2020)
Add
Compare
Today's Range
C$0.04
Now: C$0.04
C$0.04
50-Day Range
C$0.04
MA: C$0.03
C$0.04
52-Week Range
C$0.02
Now: C$0.04
C$0.12
Volume1,000 shs
Average Volume20,281 shs
Market CapitalizationC$769,510.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) Vs. BCT, RVV, PBS, MFS, CHV, and PREV

Should you be buying COT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Cotinga Pharmaceuticals Inc. (COT.V), including BriaCell Therapeutics (BCT), Revive Therapeutics (RVV), Pacgen Life Science Co. (PBS.V) (PBS), Medifocus Inc. (MFS.V) (MFS), (CHV) (CHV), and (PREV) (PREV).

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, valuation, profitability, dividends, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Cotinga Pharmaceuticals Inc. (COT.V) and BriaCell Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A
BriaCell Therapeutics0000N/A

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and BriaCell Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A
BriaCell TherapeuticsN/AN/AN/A

Valuation & Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and BriaCell Therapeutics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30
BriaCell TherapeuticsN/AN/AN/AC($5.18)-0.81

BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Summary

Cotinga Pharmaceuticals Inc. (COT.V) beats BriaCell Therapeutics on 2 of the 2 factors compared between the two stocks.

Revive Therapeutics (CVE:RVV) and Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

Valuation & Earnings

This table compares Revive Therapeutics and Cotinga Pharmaceuticals Inc. (COT.V)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revive TherapeuticsN/AN/AN/AC($0.02)-3.64
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30

Revive Therapeutics is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Revive Therapeutics and Cotinga Pharmaceuticals Inc. (COT.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Revive Therapeutics0000N/A
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A

Profitability

This table compares Revive Therapeutics and Cotinga Pharmaceuticals Inc. (COT.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Revive TherapeuticsN/AN/AN/A
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A

Pacgen Life Science Co. (PBS.V) (CVE:PBS) and Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, valuation, dividends and earnings.

Dividends

Pacgen Life Science Co. (PBS.V) pays an annual dividend of C$0.09 per share and has a dividend yield of 300.0%. Cotinga Pharmaceuticals Inc. (COT.V) pays an annual dividend of C$0.24 per share and has a dividend yield of 685.7%. Pacgen Life Science Co. (PBS.V) pays out -1,500.0% of its earnings in the form of a dividend. Cotinga Pharmaceuticals Inc. (COT.V) pays out -208.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Pacgen Life Science Co. (PBS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pacgen Life Science Co. (PBS.V)N/AN/AN/A
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for Pacgen Life Science Co. (PBS.V) and Cotinga Pharmaceuticals Inc. (COT.V), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pacgen Life Science Co. (PBS.V)0000N/A
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A

Valuation & Earnings

This table compares Pacgen Life Science Co. (PBS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pacgen Life Science Co. (PBS.V)C$302,079.006.44C$-388,896.00C($0.01)-5.00
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30

Cotinga Pharmaceuticals Inc. (COT.V) has lower revenue, but higher earnings than Pacgen Life Science Co. (PBS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Summary

Pacgen Life Science Co. (PBS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 3 of the 5 factors compared between the two stocks.

Medifocus Inc. (MFS.V) (CVE:MFS) and Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Analyst Ratings

This is a breakdown of recent recommendations for Medifocus Inc. (MFS.V) and Cotinga Pharmaceuticals Inc. (COT.V), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medifocus Inc. (MFS.V)0000N/A
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A

Profitability

This table compares Medifocus Inc. (MFS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medifocus Inc. (MFS.V)N/AN/AN/A
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A

Earnings & Valuation

This table compares Medifocus Inc. (MFS.V) and Cotinga Pharmaceuticals Inc. (COT.V)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30

Cotinga Pharmaceuticals Inc. (COT.V) has lower revenue, but higher earnings than Medifocus Inc. (MFS.V). Medifocus Inc. (MFS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Summary

Medifocus Inc. (MFS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 2 of the 3 factors compared between the two stocks.

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A
(CHV)N/AN/AN/A

Valuation & Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (CHV)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30
(CHV)N/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Cotinga Pharmaceuticals Inc. (COT.V) and (CHV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A
(CHV)0000N/A

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A
(PREV)N/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Cotinga Pharmaceuticals Inc. (COT.V) and (PREV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A
(PREV)0000N/A

Valuation & Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and (PREV)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30
(PREV)N/AN/AN/AN/AN/A


Cotinga Pharmaceuticals Inc. (COT.V) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BCT
BriaCell Therapeutics
0.5$4.18-2.4%C$4.48 millionN/A-0.81
RVV
Revive Therapeutics
0.5$0.08-12.5%C$3.62 millionN/A-3.64Earnings Announcement
High Trading Volume
Gap Down
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03-16.7%C$1.30 millionC$302,079.00-5.00Gap Down
MFS
Medifocus Inc. (MFS.V)
0.5$0.01-0.0%C$925,000.00C$2.23 million-1.00
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5$2.95-2.7%C$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
LTY
Liberty Biopharma
0.6$2.00-100.0%C$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
SCYB
Scythian Biosciences
0.5$3.49-6.3%C$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis Inc. (ABCN.V)
0.6$1.32-5.3%C$0.00N/A0.00Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.